Table 1.
Characteristics of the present study
| Variables | Control (n=25) | T2DM (n=80) | P |
|---|---|---|---|
| Age (years) | 43.98±3.21 | 44.71±3.63 | 0.33 |
| Body weight (kg) | 81.77±8.83 | 99.85±9.53 | 0.0001 |
| Height (m) | 179.77±3.88 | 179.34±3.21 | 0.57 |
| Concurrent diseases | |||
| Hypertension | 0 | 69 (86.25) | |
| Dyslipidemia | 0 | 77 (96.25) | |
| Peripheral vascular diseases | 0 | 11 (13.75) | |
| Asthma | 0 | 5 (6.25) | |
| COPD | 0 | 9 (11.25) | |
| IHD | 0 | 75 (93.75) | |
| Current therapy | |||
| Metformin | 0 | 29 (36.25) | |
| Glyburide | 0 | 30 (37.5) | |
| Metformin + glyburide | 0 | 21 (26.25) | |
| Other drugs | |||
| Statins | 0 | 78 (97.5) | |
| Omega-3 fatty acid | 0 | 73 (91.25) | |
| Antiplatelets | 0 | 74 (92.5) | |
| Anticoagulants | 0 | 5 (6.25) | |
| Theophylline | 0 | 9 (11.25) | |
| ACEI | 0 | 44 (55) | |
| CCBs | 0 | 12 (15) | |
| Trimetazidine | 0 | 39 (48.75) | |
| Tonics | 6 (7.5) | 72 (90) | 0.0001 |
Data are expressed as mean±SD, n (%), unpaired t-test was used. BMI: Body mass index, WHR: Waist-hip ratio, COPD: Chronic obstructive pulmonary disease, IHD: Ischemic heart disease, ACEI: Angiotensin converting enzyme inhibitor, CCBs: Calcium channel blockers, T2DM: Type 2 diabetes mellitus, SD: Standard deviation